Article metrics

Download PDFPDF

631 Phase I dose escalation study in patients with advanced solid tumors with ANV419, a novel fusion protein selective for IL-2Rβ/γ
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022210015
Dec 20223604
Jan 20233608
Feb 20236203
Mar 20233006
Apr 20235009
May 20234208
Jun 20232602
Jul 20232601
Aug 20232805
Sep 20232005
Oct 20231802
Nov 20234003
Dec 20233204
Jan 20241401
Feb 2024801
Mar 20242406
Apr 20244003
May 20242201
Jun 20241804
Jul 20244603
Aug 20242404
Total852098